PolyPeptide Group AG (SWX:PPGN)

PolyPeptide Group AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	59.03	74.59	68.28	95.71	37.53	136.3
Cash & Short-Term Investments	59.03	74.59	68.28	95.71	37.53	136.3
Cash Growth	-23.03%	9.25%	-28.66%	155.03%	-72.47%	692.09%
Accounts Receivable	90.2	64.31	86.26	78.78	49.15	67.79
Other Receivables	11.46	22.66	21.2	17.21	13.27	8.14
Receivables	101.66	86.96	107.46	95.98	62.41	75.92
Inventory	163.36	154.25	146.35	128.51	145.07	113
Prepaid Expenses	-	5.76	5.99	5.09	5	4.75
Other Current Assets	24.29	3.32	0.14	1.32	1.56	1.63
Total Current Assets	348.34	324.88	328.22	326.6	251.57	331.61
Property, Plant & Equipment	479.99	458.79	388.99	324.11	297.29	235.44
Long-Term Investments	9.09	7.51	5.16	5.24	2.77	3.47
Other Intangible Assets	6.47	13.91	15.02	16.45	15.87	14.27
Long-Term Deferred Tax Assets	15.4	19.31	17.62	16.69	8.29	10.26
Long-Term Deferred Charges	1.48	1.56	1.56	-	-	-
Total Assets	860.77	825.96	756.58	689.09	575.78	595.04

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	70.68	74.31	73.26	60.91	45.93	28.48
Accrued Expenses	-	28.22	22.54	24.02	17.19	20.48
Current Portion of Long-Term Debt	22.03	1.91	31.91	42.48	1.1	1.15
Current Portion of Leases	4.44	5.01	5.07	4.45	3.57	3.06
Current Income Taxes Payable	1.59	1.58	0.36	0.23	0.07	4
Current Unearned Revenue	77.25	74.17	60.48	42.97	27.54	46.13
Other Current Liabilities	36.11	1.34	0.89	1.39	0.66	0.67
Total Current Liabilities	212.1	186.53	194.5	176.45	96.05	103.96
Long-Term Debt	107.64	118.47	48.93	58.98	9.41	10.3
Long-Term Leases	15.11	15.98	18.98	18.87	17.65	14.95
Long-Term Unearned Revenue	138.05	127.85	99.64	23.16	-	-
Pension & Post-Retirement Benefits	29.25	29.85	32.13	25.11	26.64	38.98
Long-Term Deferred Tax Liabilities	3.48	3.89	3.21	3.64	1.88	1.11
Other Long-Term Liabilities	3.94	2.79	1.94	1.65	2.48	4.57
Total Liabilities	509.56	485.36	399.33	307.86	154.11	173.87

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.3	0.3	0.3	0.3	0.3	0.3
Additional Paid-In Capital	203.13	203.13	203.13	203.13	203.13	212.8
Retained Earnings	131.81	122.63	140.48	165.14	214.15	196.03
Treasury Stock	-5.82	-6.47	-8.4	-10.39	-13.61	-1.19
Comprehensive Income & Other	21.79	21.01	21.73	23.05	17.71	13.23
Shareholders' Equity	351.21	340.6	357.24	381.23	421.68	421.17
Total Liabilities & Equity	860.77	825.96	756.58	689.09	575.78	595.04

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	149.21	141.36	104.89	124.78	31.72	29.45
Net Cash (Debt)	-90.18	-66.77	-36.61	-29.08	5.8	106.85
Net Cash Growth	-	-	-	-	-94.57%	-
Net Cash Per Share	-2.76	-2.02	-1.11	-0.88	0.18	3.33
Filing Date Shares Outstanding	33.02	33.01	33	32.97	32.93	33.1
Total Common Shares Outstanding	33.02	33.01	33	32.97	32.93	33.1
Working Capital	136.25	138.34	133.72	150.15	155.52	227.65
Book Value Per Share	10.64	10.32	10.83	11.56	12.81	12.72
Tangible Book Value	344.75	326.69	342.23	364.77	405.81	406.91
Tangible Book Value Per Share	10.44	9.90	10.37	11.06	12.33	12.29
Land	-	142.33	147.37	129.94	124.02	87.67
Machinery	-	363.09	319.81	243.43	201.16	170.55
Construction In Progress	-	141.38	88.43	91.17	98.64	87.4

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 9, 2026

Data Sources Report a data error